Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells (2017)
- Authors:
- Machado Neto, João Agostinho
- Coelho-Silva, Juan Luiz
- Lucena-Araujo, Antonio R. - Universidade Federal de Pernambuco (UFPE)
- Scheucher, Priscila Santos
- Melo, Raul Antônio Morais
- Bittencourt, Rosane
- Pasquini, Ricardo
- Pagnano, Katia B. B - Universidade Estadual de Campinas (UNICAMP)
- Fagundes, Evandro Maranhão
- Chauffaille, Maria de Lourdes - Universidade Federal de São Paulo (UNIFESP)
- Chiattone, Carlos
- Rego, Eduardo Magalhães
- Traina, Fabiola
- Machado Neto, João Agostinho
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; SCHEUCHER, PRISCILA SANTOS - FMRP ; REGO, EDUARDO MAGALHÃES - FMRP ; TRAINA, FABÍOLA - FMRP
- Unidades: ICB; FMRP
- Subjects: LEUCEMIA; DOENÇAS HEMATOLÓGICAS
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Conference titles: Annual meeting and Exposition of American Society of Hematology (ASH)
-
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/2514. Acesso em: 07 maio 2024. , 2017 -
APA
Machado Neto, J. A., Coelho-Silva, J. L., Lucena-Araujo, A. R., Scheucher, P. S., Melo, R. A. M., Bittencourt, R., et al. (2017). Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/2514 -
NLM
Machado Neto JA, Coelho-Silva JL, Lucena-Araujo AR, Scheucher PS, Melo RAM, Bittencourt R, Pasquini R, Pagnano KBB, Fagundes EM, Chauffaille M de L, Chiattone C, Rego EM, Traina F. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells [Internet]. Blood. 2017 ; 130[citado 2024 maio 07 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/2514 -
Vancouver
Machado Neto JA, Coelho-Silva JL, Lucena-Araujo AR, Scheucher PS, Melo RAM, Bittencourt R, Pasquini R, Pagnano KBB, Fagundes EM, Chauffaille M de L, Chiattone C, Rego EM, Traina F. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells [Internet]. Blood. 2017 ; 130[citado 2024 maio 07 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/2514 - A inibição farmacológica de IRS1/2 induz apoptose em células BCR-ABL1 T315I
- IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
- Stathmin 1 é altamente expressa em leucemia promielocítica aguda e a dinâmica dos microtúbulos é um alvo potencial para células PML-RAR resistentes ao atra
- A ativação da via IGF1R prediz prognóstico e representa uma estratégia terapêutica em leucemia mieloide aguda
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells
- Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
- Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
